Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.
Leukemia
; 33(9): 2315-2319, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-30962578
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2019
Type:
Article